AKTX Akari Therapeutics Plc

1.91
+0.01  (+1%)
Previous Close 1.9
Open 1.9
Price To Book 4.66
Market Cap 29140744
Shares 15,256,934
Volume 10,661
Short Ratio
Av. Daily Volume 21,990

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due 2019.
Coversin - CAPSTONE
Paroxysmal nocturnal hemoglobinuria (PNH)
Phase 1/2 data due 1Q 2019.
Coversin
Atopic keratoconjunctivitis
Phase 2 data due 1Q 2019.
Coversin
Bullous Pemphigoid
Phase 2 data due 1H 2019.
Coversin
Atypical hemolytic-uremic syndrome (aHUS)